cdould be panic time for those with orders to "buy under a buck" also for shorts to "cover under a buck"
If they are as well-connected, as we hear, they can get the federal authorities to start the daisy chain, get phone, text, email, bank, credit card records. Get some bright young agents to start connecting the dots. Who had lunch with whom, on what day and then started naked-shorting, and who hires a schlock law firm, and a ghost writer and who's connected with whom, who is benefitting from fraud. How much did they gain, how much did the innocent lose, and (here's the best part) what are the TREBLE DAMAGES, and who gets to pay the piper?
They usually show EVERYTHING, but not this, it happens just to try to scare folks from their stock. Maybe one of these nuts will get a virus and need NNVC to stay alive. I say DENY the sob.
I've been involved (as a victim) several times in a stock getting hurt by these scam artists. Nothing ever comes of it, except that the short interest goes down. Some say it's a good sign because it means the shorts know something good is coming and need to cover soon.
...then what about Solyndra? Political contributors got $500 million in tax payer dollars for a failing company. Will Mr. Obama's Justice Department go after the president for that? Or for the Ambassadorships that went to donors?
If this isn't political, what the HXXX is?
Q. Am I smarter than Drs Mullan and Chapman?
A. Probably not.
Q. Do I know more about Anatabloc than Drs Mullan and Chapman?
A. Absolutely not.
Q. Do Drs Mullan and Chapman know more about the company and its prospects than I?
A. Without a doubt.
Q. Have I personally benefited from Anatabloc?
A. Yes and several friends and family members, some very substantially
Q. Have Drs Mullan and Chapman said they are “enthusiastically leading the company” ?
A. Yes, as expressed less than a day ago.
Good enough for me, especially at these low prices.
Mine came yesterday, along with a FREE sample of the anatabloc cream - had to arm wrestle my wife for it. (She won.)
Goodbye (old) Star Scientific -- Hello (new) Rock Creek Pharmaceuticals
Old Star Scientific the company of Jonnie Williams (Entrepreneur/Promoter), Paul Perito (Harvard Lawyer) CigRx, tobacco products, smoke and mirrors.
Rock Creek Pharmaceuticals the company of Dr. Michael Mullan (world renown researcher) and Dr. Christopher Chapman (successful Medical Doctor/researcher/businessman) and a world class anti-inflammatory platform with vast potential.
Today, people are selling Star Scientific, Jonnie Williams and Paul Perito.
Tomorrow they will be buying Rock Creek Pharmaceuticals, Michael Mullan, MD, Christopher Chapman, MD, and this remarkable anti-inflammatory platform.
Today is the end of one era, and the beginning of a new one. Welcome aboard!
Great post. I sold some for tax reasons (lucky me) I am buying back today - I KNOW a TRIPLE BOTTOM when I see one.
neutricutical companies and doesn't interfere with sales. It WOULD have an influence IF Anatabloc made medical claims which it does NOT. Hopefully it will one day when anatabloc is approved for certain pharmaceutical uses. (That's why Mullan and Chapman are on board!)
in 31 days, so he's in a hurry to get it done today or tomorrow.
I'm in Florida right now and heard three Anatabloc commercials in past week both on regular radio and satellite radio. Best guess - they are TARGETING the best markets - older and more up-scale. Looked like it was in conjunction with GNC (they were mentioned in the commercials) who knows a lot more about marketing than the folks at Star.
Enzo Contract Claims Trimmed In Affymetrix Med Testing Row
Share us on:
By Michael Lipkin 0 Comments
Law360, Los Angeles (December 09, 2013, 6:44 PM ET) -- A New York federal judge on Friday pared most claims from Enzo Biochem Inc.’s suit alleging Affymetrix Inc. had breached a contract allowing it to distribute Enzo’s products for detecting nucleic acids, ruling Enzo had not provided enough information to back the claims up.
U.S. District Judge Richard J. Sullivan partially granted Affymetrix’s motion for summary judgment and tossed three of Enzo’s claims, including a claim that Affymetrix had not used reasonable efforts to sell Enzo’s chemical reagents under the terms of a 1998 distribution agreement....